Effectiveness of 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve, Compensated Cirrhotic Patients With Chronic Hepatitis C Infection
Advances in Therapy - United States
doi 10.1007/s12325-020-01301-5
Full Text
Open PDFAbstract
Available in full text
Date
April 11, 2020
Authors
Publisher
Springer Science and Business Media LLC